TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
JUST IN | Sam Bankman-Fried sentenced to 25 years in prison for FTX fraud
TRENDING | US economic growth for last quarter is revised up slightly to a healthy 3.4% annual rate
TRENDING | E-insurance to become mandatory from April 1 — what it means for policyholders
TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
JUST IN | Sam Bankman-Fried sentenced to 25 years in prison for FTX fraud
TRENDING | US economic growth for last quarter is revised up slightly to a healthy 3.4% annual rate
TRENDING | E-insurance to become mandatory from April 1 — what it means for policyholders
TRENINDG | India's fiscal deficit at 86.5% full-year target in February-end 2024
Join Us
Language
English
हिन्दी
Latest news
Markets
Economy
Personal Finance
India
World
Special Coverage
World Cup 2023
G20 Coverage
Diwali 2023
Chandrayaan 3
Election 2023
Assembly Elections 2023
Election Analysis
Lok Sabha Election 2024
Upcoming Events
Engage with CNBC-TV18
Photos
Videos
Minis
Web Stories
Polls
Quiz
Healthcare
Politics
Travel
Education & Careers
Sports
Views
Auto
Entertainment
Technology
Startups
Lifestyle
Retail
Real Estate
Minis
India Business Leader Awards
Branded Content
The Growth Summit
Ceo awards
Accelerate Your Cloud Journey
Accelerating to a Connected Future
Financial Services Cloud Symposium
Crypto
Education Next
Ey Entrepreneur Of The Year
IRMA
Wizards of finance
The Thought League
Discover CNBCTV18
About
Contact
Advertise
Disclaimer
Terms of Use
Privacy Policy
Shows
Anchors
Polls
11:11 Newsletter
Life
Watch Live TV
Market
Personal Finance
Business
Economy
Featured
NextGen
LIVE TV
New
CNBC-TV18 Accelerate
New
AI Alliance Pune
New
Election Exchange
New
SME Champion Awards
New
Latest News
Live
Market Live
Nifty
Sensex
MCX
Home
Latest News
Featured
Live TV
CNBC-TV18
CNBC Awaaz
CNBC Bajar
Market Live
Minis
Podcasts
CNBC-TV18 Specials
Young Turks
Mind Matters
Climate Clock
Marquee Nights
Future Female Forward
11:11 Newsletter
Photos
Sections
Market
Global Markets
Stocks
Money
Companies
Economy
Technology
Cryptocurrency
Terms and Conditions
Disclaimer
Terms of Use
Privacy Policy
home
Mylan News
Mylan NEWS
All
News
Photo
Video
market | Sept 6, 2022 5:48 PM IST
Pfizer declares interim dividend of Rs 30 per share after sale of Upjohn business
business | Jan 14, 2022 5:27 PM IST
Exclusive: Biocon Biologics merger with Mylan's biosimilar business in final stages; announcement likely soon
healthcare | Dec 9, 2021 12:37 PM IST
Excl: Biocon in talks with Mylan to merge biosimilar businesses; IPO likely post merger
healthcare | Apr 22, 2021 2:54 PM IST
Gland Pharma begins making Remdesivir for Indian market; looks to push up production
business | Apr 9, 2021 1:50 PM IST
Remdesivir shortage: Cipla, Cadila ramping-up production
healthcare | Dec 25, 2020 2:29 PM IST
USFDA informs Biocon Biologics, Mylan of deferred action on Avastin biosimilar license application
healthcare | Dec 14, 2020 12:22 PM IST
Biocon, Mylan's diabetic drug receives positive opinion from European Medicines Agency committee
healthcare | Jun 12, 2020 1:17 PM IST
On track for launching Semglee in US in Q2FY21: Biocon’s Kiran Mazumdar Shaw
healthcare | Jun 12, 2020 8:40 AM IST
Biocon and Mylan receive US FDA approval for Semglee
healthcare | Jun 1, 2020 1:10 PM IST
Biocon partner Mylan gets favorable ruling in patent case on Insulin Glargine
healthcare | May 12, 2020 9:10 PM IST
COVID-19 treatment: Gilead signs licensing agreement for remdesivir with Cipla, Jubilant Life, Mylan, two others
healthcare | Mar 11, 2020 11:47 AM IST
US Court rules in favour of Mylan and Biocon on patent litigation covering Lantus SoloSTAR device
healthcare | Feb 24, 2020 11:31 AM IST
Confident of addressing 3 USFDA observations for Malaysia unit expeditiously, says Biocon
healthcare | Feb 20, 2020 1:07 PM IST
Coronavirus concerns: Need to take immediate steps to address possible shortages if crisis extends, says Biocon
healthcare | Feb 11, 2020 1:15 PM IST
Crucial weeks ahead for Biocon amid growing competition in trastuzumab market, regulatory inspections
Most Read
Share Market Live
View All
Top Gainers
Top Losers
Currency
Commodities
Currency
Price
Change
%Change